Advertisement
Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Avian Flu Spreading in Southwest British Columbia

December 12, 2014 9:27 am | News | Comments

Avian influenza poses little danger to people as long as poultry meat is handled and cooked properly. Read more...                         

TOPICS:

Avian Flu Spreading in Southwest British Columbia

December 12, 2014 9:27 am | News | Comments

Avian influenza poses little danger to people as long as poultry meat is handled and cooked properly. Read more...                         

TOPICS:

Mali: Last Known Ebola Case Cured, Released

December 12, 2014 9:22 am | by Sarah Dilorenzo - Associated Press | News | Comments

The last Ebola patient being treated in Mali has survived the disease and been released. Read more...                           

TOPICS:
Advertisement

Minnesota Board Won't Set Rules on Execution Drugs

December 11, 2014 2:09 pm | by Brian Bakst - Associated Press | News | Comments

Minnesota pharmacy regulators declined Wednesday to set a pioneering policy sought by death-penalty opponents that would explicitly bar the manufacture of lethal drugs for use in executions elsewhere. Read more...        

TOPICS:

Drug Class Shows Promising Results for Breast Cancer Therapy

December 11, 2014 11:53 am | News | Comments

A new class of drugs could help overcome resistance to standard treatments. Read more...                             

TOPICS:

Epidemics Are Optional

December 11, 2014 11:37 am | by Kalpana Jain, Harvard Divinity School Communications | News | Comments

The large number of deaths from the Ebola virus is primarily due to the lack of sufficient medical care where it’s needed most. Read more...                    

TOPICS:

Merck Advancing Breast Cancer Drug to Mid-Stage

December 11, 2014 11:33 am | by Linda A. Johnson - AP Business Writer | News | Comments

Merck said it will start mid-stage patient tests of Keytruda in the first half of 2015. Read more...                           

TOPICS:

Patient with Exposure to Ebola to be Admitted at NIH Clinical Center

December 11, 2014 11:30 am | News | Comments

Later today, the National Institutes of Health expects to admit a patient with exposure to the Ebola virus to the NIH Clinical Center’s special clinical studies unit for observation and to enroll in a clinical protocol. The patient is an American nurse who was volunteering services in an Ebola treatment unit in Sierra Leone. Read more...

TOPICS:
Advertisement

Supporting Drug Development Process with Raman Spectroscopy

December 11, 2014 11:25 am | by Kathleen A. Martin, Ph.D., Senior Research Chemist, McCrone Associates, Inc. | Articles | Comments

Raman spectroscopy has steadily gained a wider role in the pharmaceutical industry because of its applicability to several important aspects of drug development and manufacturing. Read more...                         

TOPICS:

Ebola Vaccine Trial Suspended After Side Effects

December 11, 2014 9:17 am | by Associated Press | News | Comments

Swiss researchers have suspended the testing of one of the leading Ebola vaccine candidates after some volunteers reported unexpected side effects. Read more...                                

TOPICS:

‘Placebo Therapy’ Ineffective For Long-Term Chronic Pain Relief

December 11, 2014 9:13 am | News | Comments

Scientists at the University of Liverpool have shown that ‘placebo therapy’ could be effective for short-term pain relief in patients with Complex Regional Pain Syndrome (CRPS), but does not have a lasting impact. Read more...                              

TOPICS:

Actavis Launches Generic Version of Celebrex

December 11, 2014 9:09 am | News | Comments

Actavis plc announced that it has launched a generic version of Celebrex (celecoxib) 50 mg, 100 mg, 200 mg and 400 mg capsules, as part of a settlement agreement with Pfizer, Inc.  Read more...                                   

TOPICS:

Gilead Faces Lawsuit Over Hepatitis C Drug Pricing

December 11, 2014 8:49 am | News | Comments

Gilead has been selling a 12-week treatment of Sovaldi in the United States for approximately $84,000, or $1,000 per pill. Read more...                     

TOPICS:

Targeting Enzyme May Reduce Chemo Drug's Cardiac Side Effects

December 10, 2014 4:56 pm | by Massachusetts General Hospital | News | Comments

MGH investigators identified two compounds that appear to block the cardiac damage caused by the important chemotherapy drug doxorubicin. Their report in the issue of Science Translational Medicine indicates that inhibiting the action of an enzyme that is key to the generation of cellular energy in mitochondria could prevent doxorubicin-induced damage to cardiac cells. Read more...

TOPICS:

New HPV Vaccine Strengthens Cancer Protection

December 10, 2014 4:42 pm | by Associated Press | News | Comments

The drugmaker Merck & Co. Inc. has received approval for an updated version of its Gardasil vaccine that protects against an additional five strains of the virus that causes most cases of cervical cancer. Read more..                  

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading